Skip to main content
Premium Trial:

Request an Annual Quote

David Goldstein Becomes Director of Duke s Center for Population Genomics and Pharmacogenomics; Elizabeth Nabel New Director of NHLBI; Melissa Cline Leaves Affy for Pasteur Institute; and Others

David Goldstein has been appointed as director of the Center for Population Genomics and Pharmacogenetics at Duke University's Institute for Genome Sciences & Policy, Duke said last week. He will hold a joint appointment as professor in the departments of molecular genetics and microbiology and biology at Duke. Goldstein joins Duke from University College London, where he has been a professor of genetics in the department of biology since 1999. He holds a PhD from StanfordUniversity and a BS from the Universityof California.


 

Elizabeth Nabel has become the new director of the National Heart, Lung, and Blood Institute, NIH said last week. Nabel, a board certified cardiologist, joined the NHLBI in 1999 as the institute's scientific director of clinical research. She holds an MD from CornellUniversityMedicalCollege.


 

Melissa Cline has left her post as a bioinformatics scientist at Affymetrix to join Benno Schwikowski's lab at the Pasteur Institute in Paris, according to BioInform, a GenomeWeb newsletter.


 

Peter Tunon has become president and Thomas Guiel chief operating officer of Cellectricon's new wholly-owned USsubsidiary of the same name, the company said on Monday. The subsidiary will be headquartered in Gaithersburg, Md.

 

Tunon used to be a manager at Bio-Rad Laboratories, Invitrogen Life Technologies, and GraceVydac.

 

Guiel previously held a position at Invitrogen Life Technologies where he was responsible for establishing manufacturing, ordering, and distribution operations worldwide.


 

Following the acquisition of ActivX Biosciences by Kyorin Pharmaceutical of Japan, John Kozarich has become chairman and president of ActivX, now a wholly-owned subsidiary of Kyorin, as well as chief scientific advisor of Kyorin, ActivX said today. He used to be president and chief R&D officer of ActivX.


 

William Rastetterhas become non-executive chairman of the board of directors, and John Stuelpnagel promoted to the new position of chief operating officer of Illumina, the San Diego-based company said last week.

 

Rastetter, who has been a member of Illumina's board since 1998, is the executive chairman of Biogen Idec. Prior to the merger of Idec and Biogen, he was chairman and CEO of Idec Pharmaceuticals. He holds a PhD from HarvardUniversity.

 

Stuelpnagel is a founder of Illumina.


 

Tina Nova was appointed to the board of directors of Cyntellect, the San Diego-based company said last week. She is the president, CEO, and co-founder of Genoptix. Nova also co-founded Nanogen, where she was chief operating officer and president from 1994 to 2000. Nova holds a PhD in biochemistry from the Universityof California, Riverside.


 

Alex Moghadam was named as vice president for international operations for Zoll Medical, the company said last month. Moghadam joins the firm from Thermo Electron, where he headed the Bioscience Technologies division in Europe, Middle East, and Africa.


 

Jim Richeyhas become a senior advisor of business development, and Charles Campbell a member of the scientific advisory board of Lumera, the Bothell, Wash.-based company said last month.

 

Richey has held senior executive positions at LJL BioSystems, PerSeptive BioSystems, Pharmacia Biosensor, and Pharmacia Biotech.

 

Campbellis a professor of chemistry at the Universityof Washingtonand a co-director of the University of Washington/PNNL Joint Institute for Nanotechnology.


 

Gerald Longa has joined the board of directors of BioStorage Technologies, the Indianapolis, Ind.-based biorepository company said last week. He is the president and co-owner of Terre HauteMedical Laboratory and Pathology Associates of Terre Haute. He is also a clinical associate professor of pathology at the Indiana University School of Medicine.


 

David Doddhas been elected as chair of the board of directors of the American Foundation for Suicide Prevention, AFSP said last week. He is the president and CEO of Serologicals.


 

Accelryshas appointed nine members to a new scientific advisory board of its nanotechnology consortium, the San Diego-based company said last week. The members are: Richard Catlow, a professor of chemistry at University College London; Tim Clark, technical director of the Computer-Chemie-Centrum in Erlangen, Germany; Alessandro De Vita, an assistant professor in materials engineering at the University of Trieste in Italy; Julian Gale, a professor of computational chemistry at Curtin University of Technology in Perth, Australia; Sharon Glotzer, an associate professor of chemical engineering, materials science and engineering, macromolecular science and engineering, and physics at the University of Michigan in Ann Arbor; Yoshiyuki Kawazoe, a professor of materials design by computer simulation at Tohoku University in Japan; Mike Payne, a professor of computational physics at Cambridge University, UK; Ruben Perez, an associate professor at Universidad Autonoma in Madrid; and Alan Windle, a professor in the department of materials science and metallurgy at Cambridge University.


 

The National Institutes of Health have appointed four new members to the National Advisory Allergy and Infectious Diseases Council, which advises the NIAID, NIH said last week. The new council members are: Richard Insel, an executive vice president of research at the Juvenile Diabetes Research Foundation International in New York; Martin Myers, a professor of pediatrics and preventive medicine and community health at the University of Texas Medical Branch, Galveston; Shelley Payne, a professor of molecular genetics and microbiology at the University of Texas at Austin; and Gary Schoolnik, a professor of medicine, microbiology, and immunology at the Stanford Medical School.


 

Ewan Birneyof the European Bioinformatics Institute will receive the 2005 Benjamin Franklin Award in Bioinformatics. Bioinformatics.Org makes the award annually to an individual who has "promoted free and open access to the materials and methods used in the scientific field of bioinformatics." The award will be presented at the annual meeting of Bioinformatics.Org in Bostonon May 19.


 

Marvin Caruthers and David Bartel are among 17 scientists who will receive awards from the National Academy of Sciences to honor their outstanding scientific achievements. The awards will be presented on May 2 at a ceremony in Washington, DC.

 

Caruthers will receive the $20,000 NAS award for chemistry in service to society for his invention and development of chemical reagents and methods used for the automated synthesis of DNA oligonucleotides. He is a professor in the department of chemistry and biochemistry at the Universityof Colorado in Boulder.

 

Bartel will receive the $25,000 NAS award in molecular biology for his discoveries on the repertoire of catalytic RNA and the analysis of micro RNA genes and their targets. He is a professor of biology at the Massachusetts Institute of Technology and a member of the Whitehead Institute for Biomedical Research.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.